Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 2,294 | 2,966 | 2,373 | 4,678 | 4,853 |
| Operating Income | -2,294 | -2,966 | -2,373 | -4,678 | -4,853 |
| Interest Expense | 85 | 23 | -73 | 92 | 117 |
| Other Income | -715 | -10,764 | -1,402 | 22 | -4,796 |
| Pre-tax Income | -3,093 | -13,754 | -3,703 | -4,748 | -9,766 |
| Net Income Continuous | -3,093 | -13,754 | -3,703 | -4,748 | -9,766 |
| Minority Interests | 160 | -193 | -677 | 571 | -513 |
| Net Income | $-3,253 | $-13,560 | $-3,027 | $-5,319 | $-9,253 |
| EPS Basic Total Ops | -0.47 | -3.06 | -0.19 | -1.25 | -3.23 |
| EPS Basic Continuous Ops | -0.47 | -3.06 | -0.19 | -1.25 | -3.23 |
| EPS Diluted Total Ops | -0.47 | -3.06 | -0.19 | -1.25 | -3.23 |
| EPS Diluted Continuous Ops | -0.47 | -3.06 | -0.19 | -1.25 | -3.23 |
| EPS Diluted Before Non-Recurring Items | -0.47 | -3.06 | -0.71 | -1.25 | -3.23 |
| EBITDA(a) | $-2,165 | $-2,839 | $-2,244 | $-4,533 | $-4,712 |